Clenoliximab, CAS 182912-58-9

Product Description: Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. Clenoliximab can be used for the research of rheumatoid arthritis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]D R Mould, et al. A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis. Clin Pharmacol Ther. 1999 Sep;66(3):246-57.

CAS Number: 182912-58-9

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99607-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99607-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Konjugat: Unconjugated